Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,268 | -1,485 | -4,912 | -3,264 | -2,050 |
| Depreciation Amortization | -13 | -7 | -19 | -15 | -10 |
| Other Working Capital | 548 | 300 | 103 | -262 | -405 |
| Other Operating Activity | 331 | 135 | 505 | 419 | 340 |
| Operating Cash Flow | $-2,402 | $-1,057 | $-4,324 | $-3,121 | $-2,125 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,561 | 2,549 | -21 | -1,373 | -1,373 |
| PPE Investments | -10 | -1 | -27 | -26 | -25 |
| Other Investing Activity | -100 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $3,452 | $2,548 | $-48 | $-1,398 | $-1,398 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,775 | N/A | 931 | 931 | 919 |
| Financing Cash Flow | $2,775 | $N/A | $931 | $931 | $919 |
| Beginning Cash Position | 369 | 369 | 3,810 | 3,810 | 3,810 |
| End Cash Position | 4,194 | 1,860 | 369 | 222 | 1,206 |
| Net Cash Flow | $3,825 | $1,491 | $-3,440 | $-3,588 | $-2,603 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,402 | -1,057 | -4,324 | -3,121 | -2,125 |
| Capital Expenditure | -10 | -1 | -27 | -26 | -25 |
| Free Cash Flow | -2,412 | -1,058 | -4,351 | -3,147 | -2,150 |